A citation-based method for searching scientific literature

Alessandra Giustozzi, Vanda Salutari, Elena Giudice, Lucia Musacchio, Caterina Ricci, Chiara Landolfo, Maria Teresa Perri, Giovanni Scambia, Domenica Lorusso. Biology (Basel) 2021
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Sortilin as a Novel Diagnostic and Therapeutic Biomarker in Chronic Lymphocytic Leukemia.
Lia Farahi, Fatemeh Ghaemimanesh, Saeideh Milani, Seyed Mohsen Razavi, Mohammad Mehdi Akhondi, Hodjattallah Rabbani. Avicenna J Med Biotechnol 2019
7
100

Sortilin controls intracellular sorting of brain-derived neurotrophic factor to the regulated secretory pathway.
Zhe-Yu Chen, Alessandro Ieraci, Henry Teng, Henning Dall, Chui-Xiang Meng, Daniel G Herrera, Anders Nykjaer, Barbara L Hempstead, Francis S Lee. J Neurosci 2005
287
100

Response of human tumor xenografts in athymic nude mice to docetaxel (RP 56976, Taxotere).
D J Dykes, M C Bissery, S D Harrison, W R Waud. Invest New Drugs 1995
43
100

Retreatment with carboplatin and paclitaxel for recurrent endometrial cancer: A retrospective study of the Memorial Sloan Kettering Cancer Center experience.
Maria Rubinstein, Darragh Halpenny, Vicky Makker, Rachel N Grisham, Carol Aghajanian, Karen Cadoo. Gynecol Oncol Rep 2019
9
100


PARP Inhibitors in Ovarian Cancer: The Route to "Ithaca".
Stergios Boussios, Afroditi Karathanasi, Deirdre Cooke, Cherie Neille, Agne Sadauskaite, Michele Moschetta, Nikolaos Zakynthinakis-Kyriakou, Nicholas Pavlidis. Diagnostics (Basel) 2019
41
100

Human epidermal growth factor receptor 2 targeted therapy in endometrial cancer: Clinical and pathological perspectives.
Ayumi Saito, Hiroshi Yoshida, Tadaaki Nishikawa, Kan Yonemori. World J Clin Oncol 2021
2
100

TH1902, a new docetaxel-peptide conjugate for the treatment of sortilin-positive triple-negative breast cancer.
Michel Demeule, Cyndia Charfi, Jean-Christophe Currie, Alain Larocque, Alain Zgheib, Sophie Kozelko, Richard Béliveau, Christian Marsolais, Borhane Annabi. Cancer Sci 2021
6
100

Survival in recurrent ovarian cancer patients before and after the bevacizumab era: an observational single-centre study.
Huseyin Akilli, Samed Rahatli, Khayala Aliyeva, Ozden Altundag, Ulku Esra Kuscu, Ali Ayhan. J Obstet Gynaecol 2022
1
100

Cell-penetrating peptides: strategies for anticancer treatment.
Drazen Raucher, Jung Su Ryu. Trends Mol Med 2015
127
100

The multifaceted role of sortilin/neurotensin receptor 3 in human cancer development.
Fatemeh Ghaemimanesh, Majid Mehravar, Saeideh Milani, Ensieh M Poursani, Kioomars Saliminejad. J Cell Physiol 2021
3
100

Targeted drug delivery for cancer therapy: the other side of antibodies.
Michael A Firer, Gary Gellerman. J Hematol Oncol 2012
157
100

Targeted therapies in gynecological cancers: a comprehensive review of clinical evidence.
Qiao Wang, Hongling Peng, Xiaorong Qi, Min Wu, Xia Zhao. Signal Transduct Target Ther 2020
39
100

Mechanism underlying the regulation of sortilin expression and its trafficking function.
Shuhui Ouyang, Bo Jia, Wei Xie, Jing Yang, Yuncheng Lv. J Cell Physiol 2020
4
100

Adjuvant and post-surgical treatment in endometrial cancer.
Hsiu-Jung Tung, Huei-Jean Huang, Chyong-Huey Lai. Best Pract Res Clin Obstet Gynaecol 2022
2
100

Cell-penetrating peptides: 20 years later, where do we stand?
Chérine Bechara, Sandrine Sagan. FEBS Lett 2013
535
100

Neurotrophins and their receptors in early development of the mammalian nervous system.
Katarzyna Bartkowska, Kris Turlejski, Rouzanna L Djavadian. Acta Neurobiol Exp (Wars) 2010
78
100

Sortilin is associated with breast cancer aggressiveness and contributes to tumor cell adhesion and invasion.
Séverine Roselli, Jay Pundavela, Yohann Demont, Sam Faulkner, Sheridan Keene, John Attia, Chen Chen Jiang, Xu Dong Zhang, Marjorie M Walker, Hubert Hondermarck. Oncotarget 2015
38
100

Cancer statistics, 2020.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2020
100


Ovarian Cancer: An Integrated Review.
Christine Stewart, Christine Ralyea, Suzy Lockwood. Semin Oncol Nurs 2019
210
100

Epithelial ovarian cancer: Evolution of management in the era of precision medicine.
Stephanie Lheureux, Marsela Braunstein, Amit M Oza. CA Cancer J Clin 2019
380
100

New Peptide-Drug Conjugates for Precise Targeting of SORT1-Mediated Vasculogenic Mimicry in the Tumor Microenvironment of TNBC-Derived MDA-MB-231 Breast and Ovarian ES-2 Clear Cell Carcinoma Cells.
Cyndia Charfi, Michel Demeule, Jean-Christophe Currie, Alain Larocque, Alain Zgheib, Bogdan Alexandru Danalache, Amira Ouanouki, Richard Béliveau, Christian Marsolais, Borhane Annabi. Front Oncol 2021
1
100


Therapeutic applications of cell-penetrating peptides.
Randolph M Johnson, Stephen D Harrison, Derek Maclean. Methods Mol Biol 2011
85
100

PAK Kinases Target Sortilin and Modulate Its Sorting.
Lone Tjener Pallesen, Camilla Gustafsen, Jacob Flyvholm Cramer, Steen Vang Petersen, Søren Skou Thirup, Peder Madsen, Claus Munck Petersen. Mol Cell Biol 2020
7
100


Other Gynecologic Cancers: endometrial, ovarian, vulvar and vaginal cancers.
Eliane Duarte-Franco, Eduardo L Franco. BMC Womens Health 2004
7
100

Neoadjuvant treatment for newly diagnosed advanced ovarian cancer: where do we stand and where are we going?
Michele Moschetta, Stergios Boussios, Elie Rassy, Eleftherios P Samartzis, Gabriel Funingana, Mario Uccello. Ann Transl Med 2020
12
100

Generation of Two Paclitaxel-Resistant High-Grade Serous Carcinoma Cell Lines With Increased Expression of P-Glycoprotein.
Mariana Nunes, Patrícia M A Silva, Ricardo Coelho, Carla Pinto, Albina Resende, Hassan Bousbaa, Gabriela M Almeida, Sara Ricardo. Front Oncol 2021
3
100

Tumor co-expression of progranulin and sortilin as a prognostic biomarker in breast cancer.
Karoline Berger, Sara Rhost, Svanheiður Rafnsdóttir, Éamon Hughes, Ylva Magnusson, Maria Ekholm, Olle Stål, Lisa Rydén, Göran Landberg. BMC Cancer 2021
3
100


Comparing Paclitaxel-Carboplatin with Paclitaxel-Cisplatin as the Front-Line Chemotherapy for Patients with FIGO IIIC Serous-Type Tubo-Ovarian Cancer.
Chen-Yu Huang, Min Cheng, Na-Rong Lee, Hsin-Yi Huang, Wen-Ling Lee, Wen-Hsun Chang, Peng-Hui Wang. Int J Environ Res Public Health 2020
20
100


Overexpression of sortilin is associated with 5-FU resistance and poor prognosis in colorectal cancer.
Sabrina Blondy, Hugo Talbot, Sofiane Saada, Niki Christou, Serge Battu, Julie Pannequin, Marie-Odile Jauberteau, Fabrice Lalloué, Mireille Verdier, Muriel Mathonnet,[...]. J Cell Mol Med 2021
4
100

The effect of sortilin silencing on ovarian carcinoma cells.
Fatemeh Ghaemimanesh, Gholamreza Ahmadian, Saeed Talebi, Amir-Hassan Zarnani, Mehrdad Behmanesh, Shayda Hemmati, Reza Hadavi, Mahmood Jeddi-Tehrani, Maryam Farzi, Mohammad Mehdi Akhondi,[...]. Avicenna J Med Biotechnol 2014
22
100

Potential efficacy of weekly low-dose administration of bevacizumab as a combination therapy for platinum-resistant ovarian carcinoma: a retrospective analysis.
Jin Suminokura, Morikazu Miyamoto, Tomoyuki Yoshikawa, Hiroko Kouta, Yoshihiro Kikuchi, Taira Hada, Hiroki Ishibashi, Tsubasa Ito, Hideki Iwahashi, Soichiro Kakimoto,[...]. BMC Cancer 2022
1
100

Current Perspectives on Taxanes: Focus on Their Bioactivity, Delivery and Combination Therapy.
Jan Škubník, Vladimíra Pavlíčková, Tomáš Ruml, Silvie Rimpelová. Plants (Basel) 2021
10
100

Endometrial Cancer.
Karen H Lu, Russell R Broaddus. N Engl J Med 2020
127
100


Mixed Endometrioid Adenocarcinoma and Müllerian Adenosarcoma of the Uterus and Ovary: Clinicopathologic Characterization With Emphasis on its Distinction From Carcinosarcoma.
Soufiane El Hallani, Rupali Arora, Douglas I Lin, Anna Måsbäc, Claudia Mateoiu, W Glenn McCluggage, Marisa R Nucci, Christopher N Otis, Vinita Parkash, Carlos Parra-Herran,[...]. Am J Surg Pathol 2021
4
100

A Review on Drug Delivery System for Tumor Therapy.
Guoxiang Liu, Lina Yang, Guang Chen, Fenghua Xu, Fanghao Yang, Huaxin Yu, Lingne Li, Xiaolei Dong, Jingjing Han, Can Cao,[...]. Front Pharmacol 2021
5
100

Ectopic Expression of Sortilin 1 (NTR-3) in Patients with Ovarian Carcinoma.
Shayda Hemmati, Amir Hassan Zarnani, Ahmad Reza Mahmoudi, Mohammad-Reza Sadeghi, Haleh Soltanghoraee, Mohammad Mehdi Akhondi, Majid Tarahomi, Mahmood Jeddi-Tehrani, Hodjattallah Rabbani. Avicenna J Med Biotechnol 2009
10
100

High interstitial fluid pressure - an obstacle in cancer therapy.
Carl-Henrik Heldin, Kristofer Rubin, Kristian Pietras, Arne Ostman. Nat Rev Cancer 2004
100

The Membrane Protein Sortilin Can Be Targeted to Inhibit Pancreatic Cancer Cell Invasion.
Fangfang Gao, Nathan Griffin, Sam Faulkner, Xiang Li, Simon J King, Phillip Jobling, Jim W Denham, Chen Chen Jiang, Hubert Hondermarck. Am J Pathol 2020
8
100

Mechanisms of Taxane Resistance.
Sara M Maloney, Camden A Hoover, Lorena V Morejon-Lasso, Jenifer R Prosperi. Cancers (Basel) 2020
31
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.